This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Association Between Clozapine-Induced Agranulocytosis and HLA Subtyping

Pilar Lopez-Garcia, Juana Teresa Rodriguez, Pilar De Castro, Ignacio Landecho, and Ricardo Zapata

Published: October 16, 2006

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Clozapine has been shown to be more effective than other antipsychotic drugs in the treatment of schizophrenia.1 Clozapine is a low-potency compound that has preferential antagonist activity at 5-HT2 receptors, followed by activity at adrenergic, cholinergic, and histamine receptors and only modest activity at D1 and D2 receptors. Despite its superior clinical profile, the use of clozapine is limited by the risk of serious and potentially life-threatening side effects, such as leukopenia and agranulocytosis.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 67

Quick Links: